InsiderAlpha

Joseph C. Galante - SEC Form 4 Insider Trading Activity

Summary

Updated Aug 4, 2026

Joseph C. Galante is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Profile

Joseph C. Galante

Joseph C. Galante serves as Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). Galante has reported 1 insider filing with the SEC since 2026. The most recent filing was in March 2026.

RoleDirector
Notability26/100

Board memberships

Reported roles

Trading Pattern

InsiderAlpha's records for Joseph C. Galante go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.

Career & Filing History

Every role Joseph C. Galante has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-03-20CPIXCUMBERLAND PHARMACEUTICALS INCA - Grant or award1.8K$2.80$5K

Most Active Insiders Right Now

Joseph C. Galante has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.

More Notable Insiders

Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:

Frequently Asked Questions

Who is Joseph C. Galante?

Joseph C. Galante serves as Director of CUMBERLAND PHARMACEUTICALS INC (CPIX). Galante has reported 1 insider filing with the SEC since 2026. The most recent filing was in March 2026.…

Where can I see all of Joseph C. Galante's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Joseph C. Galante profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.